PAYER SCIENCES EARNS SPOT ON MM+M’S AGENCY 100 LIST

By Publicis Health

Ranked at #66 in this year’s MM+M Top 100, Payer Sciences brings a specialized market access lens, with a model built around analytics, strategy, and payer-focused communications. As part of Publicis Health, the agency sits at the intersection of data and access, helping pharma and biotech clients better understand payer behavior, coverage dynamics, reimbursement barriers, and the practical decisions that shape product performance in market. 

That perspective is shaping how the agency is thinking about the future of healthcare marketing. As President Casey McCann notes, “AI is not Super Google. AI is an entire sea change. The only parallel in my career would be the actual emergence of the internet itself.” He adds that Payer Sciences’ ability to see the bigger picture and operate within Publicis Health’s model, one he describes as more seamlessly integrated and pliable than other holding company structures, is a key differentiator. 

“Leaders leading when nobody’s following are just taking a walk,” McCann says. “This is the model I’ve been looking to work in my entire career: the ability to both lead and do. It feels like I’m home — but it’s not about me, it’s about the model that’s most effective for clients.” 

What makes Payer Sciences stand out is how directly its work connects insight to action. The agency’s proprietary tools and access-focused capabilities support everything from payer segmentation and scenario planning to pull-through communications, giving brands a more disciplined way to navigate one of healthcare’s most complex audiences. Its inclusion on MM+M’s 2026 Agency 100 reinforces the growing importance of market access expertise in modern healthcare marketing and the need for smarter, more localized strategies that help innovation reach the people it was built for. 

Read the full Payer Sciences MM+M 2026 Agency 100 profile here.